INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $308,040 | -34.1% | 10,103 | -31.6% | 0.22% | -38.2% |
| Q3 2023 | $467,249 | -24.1% | 14,777 | -2.1% | 0.36% | -11.1% |
| Q2 2023 | $615,411 | +18.8% | 15,091 | +8.5% | 0.40% | +11.3% |
| Q1 2023 | $518,202 | -3.3% | 13,904 | -9.5% | 0.36% | -18.4% |
| Q4 2022 | $536,000 | -34.2% | 15,371 | +5.6% | 0.44% | -35.5% |
| Q3 2022 | $815,000 | -80.9% | 14,558 | -82.4% | 0.69% | -29.7% |
| Q2 2022 | $4,270,000 | +446.7% | 82,499 | +667.4% | 0.98% | +86.1% |
| Q1 2022 | $781,000 | -27.7% | 10,751 | +17.7% | 0.53% | -27.7% |
| Q4 2021 | $1,080,000 | -9.4% | 9,134 | +2.8% | 0.73% | -11.4% |
| Q3 2021 | $1,192,000 | -20.5% | 8,886 | -4.0% | 0.82% | -19.3% |
| Q2 2021 | $1,499,000 | +86.9% | 9,256 | -7.4% | 1.02% | +28.6% |
| Q1 2021 | $802,000 | +210.9% | 9,994 | +110.9% | 0.79% | +154.2% |
| Q4 2020 | $258,000 | – | 4,739 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |